Design Therapeutics, Inc. (DSGN)
15.11
-0.14
(-0.92%)
USD |
NASDAQ |
Aug 28, 16:00
15.09
-0.02
(-0.13%)
After-Hours: 20:00
Design Therapeutics Total Liabilities (Quarterly) : 13.27M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.27M |
| March 31, 2026 | 12.39M |
| December 31, 2025 | 14.25M |
| September 30, 2025 | 12.05M |
| June 30, 2025 | 9.849M |
| March 31, 2025 | 9.556M |
| December 31, 2024 | 9.996M |
| September 30, 2024 | 9.176M |
| June 30, 2024 | 8.34M |
| March 31, 2024 | 9.236M |
| December 31, 2023 | 11.96M |
| Date | Value |
|---|---|
| September 30, 2023 | 14.91M |
| June 30, 2023 | 14.84M |
| March 31, 2023 | 11.92M |
| December 31, 2022 | 13.83M |
| September 30, 2022 | 13.63M |
| June 30, 2022 | 10.77M |
| March 31, 2022 | 8.492M |
| December 31, 2021 | 8.427M |
| September 30, 2021 | 8.789M |
| June 30, 2021 | 3.545M |
| March 31, 2021 | 3.848M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.95B |
| AnaptysBio, Inc. | 316.94M |
| 4D Molecular Therapeutics, Inc. | 84.96M |
| Inhibrx Biosciences, Inc. | 207.20M |
| Agenus, Inc. | 378.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.13M |
| Shareholders Equity (Quarterly) | 201.86M |
| Debt to Equity Ratio | 0.0132 |
| Current Ratio | 18.86 |
| Net Debt Paydown Yield | -0.01% |